iconoclast - Thanks for the article. I like the reference to being the only drug on the market for a few years. If DM is correct with the estimate of a 6 to 8 year lead, that makes our opportunity that much bigger.
After looking at the 5 year chart for ICPT I think we would all be happy if RVX made it to the same levels they did in the first half of 2015...close to US$ 315.00 per share.
tada